Overview: Central & Peripheral Nervous System: Recent advances in the discovery and characterization of substance P antagonists

[1]  C. Swain,et al.  N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists. , 1993, Journal of medicinal chemistry.

[2]  A I Basbaum,et al.  Peptides and the primary afferent nociceptor , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  S. Wong,et al.  Fiscalins: new substance P inhibitors produced by the fungus Neosartorya fischeri. Taxonomy, fermentation, structures, and biological properties. , 1993, The Journal of antibiotics.

[4]  D. Veber,et al.  Cyclic peptides as selective tachykinin antagonists. , 1993, Journal of medicinal chemistry.

[5]  P. Thadeio,et al.  Discovery of a potent substance P antagonist: recognition of the key molecular determinant. , 1992, Journal of medicinal chemistry.

[6]  H. Morimoto,et al.  Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888 , 1992, British journal of pharmacology.

[7]  M. Okuhara,et al.  WS9326A, a novel tachykinin antagonist isolated from Streptomyces violaceusniger no. 9326. II. Biological and pharmacological properties of WS9326A and tetrahydro-WS9326A (FK224) , 1992, The Journal of antibiotics.

[8]  M. Okuhara,et al.  WS9326A, a novel tachykinin antagonist isolated from Streptomyces violaceusniger no. 9326. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. , 1992, The Journal of antibiotics.

[9]  H. Morimoto,et al.  Studies on neurokinin antagonists. 1. The design of novel tripeptides possessing the glutaminyl-D-tryptophylphenylalanine sequence as substance P antagonists. , 1992, Journal of Medicinal Chemistry.

[10]  H. Morimoto,et al.  FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity , 1992, British journal of pharmacology.

[11]  M. Logan,et al.  Synthesis and substance P receptor binding activity of androstano[3,2-b]pyrimido[1,2-a]benzimidazoles. , 1992, Journal of medicinal chemistry.

[12]  J. Peyronel,et al.  Synthesis of RP-67,580, a new potent nonpeptide substance P antagonist , 1992 .

[13]  P. Laduron,et al.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Matucci-Cerinic,et al.  Substance P and Somatostatin Levels in Rheumatoid Arthritis, Osteoarthritis, and Psoriatic Arthritis Synovial Fluid , 1991, Annals of the New York Academy of Sciences.

[15]  N. Frossard,et al.  Tachykinin receptors and the airways. , 1991, Life sciences.

[16]  J R Brown,et al.  Potent and highly selective neurokinin antagonists. , 1990, Journal of medicinal chemistry.

[17]  J. Marchand,et al.  Disulfiram administration affects substance P-like immunoreactive and monoaminergic neural systems in rodent brain. , 1990, The Journal of biological chemistry.

[18]  A. Kelley,et al.  Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures , 1989, Brain Research.

[19]  E. Escher,et al.  Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea. , 1984, European Journal of Pharmacology.

[20]  M. C. Chang,et al.  Fertilization of Denuded Rabbit Eggs in vitro by Sperm recovered from the Uterus or Vagina , 1971, Nature.

[21]  M. Chang,et al.  Amino-acid sequence of substance P. , 1971, Nature: New biology.